MSB 3.42% $1.21 mesoblast limited

Deadline for Novartis, page-178

  1. 10,833 Posts.
    lightbulb Created with Sketch. 561
    I just don't think anyone has that information. My understanding is that the deadline for the closing of the Novartis agreement was extended so they could review the covid ARDS data. And as that appears to have been delayed, the agreement would still be open and not yet at the closed or terminated stage so there is nothing to say at the moment.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.